Mild stroke: safety and outcome in patients receiving thrombolysis

Objectives The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta neurologica Scandinavica 2014-04, Vol.129 (s198), p.37-40
Hauptverfasser: Logallo, N., Kvistad, C. E., Naess, H., Waje-Andreassen, U., Thomassen, L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 40
container_issue s198
container_start_page 37
container_title Acta neurologica Scandinavica
container_volume 129
creator Logallo, N.
Kvistad, C. E.
Naess, H.
Waje-Andreassen, U.
Thomassen, L.
description Objectives The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients. Materials and methods All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria. Results Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS >5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA. Conclusions This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment.
doi_str_mv 10.1111/ane.12235
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1504454746</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3235139881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhq2KqiwfB_4AisQFDgF_xklvdLVdKgE90ApulmNPqCGJt3YC7L-vYZc9IHUuo5GeeTTzInRA8ClJdaZ7OCWUMvEJTUiBcY455ltogjEmecEI30Y7MT6kiUrOv6BtykVZCiwm6NuVa20Wh-Af4WsWdQPDMtO9zfw4GN9B5vpsoQcH_RCzAAbck-vvs-FP8F3t22V0cQ99bnQbYX_dd9Hv77Nf04v88uf8x_T8Mje8KkReMyupkNYQbYi0BalxCY2tSy51BQwzUQsGxmqGBWe1rVhJy0I3EhvbGI7ZLjpeeRfB_x0hDqpz0UDbpvf9GBURmHPBJS8SevQBffBj6NN1rxSTtKgqmaiTFWWCjzFAoxbBdTosFcHqNViVzOot2MQero1j3YHdkO9JJuBsBTy7Fpb_N6nz69m7Ml9tuDjAy2ZDh0dVSCaFur2eK0pvyoqzqbpj_wA7CY_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1503726997</pqid></control><display><type>article</type><title>Mild stroke: safety and outcome in patients receiving thrombolysis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Logallo, N. ; Kvistad, C. E. ; Naess, H. ; Waje-Andreassen, U. ; Thomassen, L.</creator><creatorcontrib>Logallo, N. ; Kvistad, C. E. ; Naess, H. ; Waje-Andreassen, U. ; Thomassen, L.</creatorcontrib><description>Objectives The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients. Materials and methods All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria. Results Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS &gt;5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA. Conclusions This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment.</description><identifier>ISSN: 0001-6314</identifier><identifier>EISSN: 1600-0404</identifier><identifier>EISSN: 1600-5449</identifier><identifier>DOI: 10.1111/ane.12235</identifier><identifier>PMID: 24588505</identifier><identifier>CODEN: ANRSAS</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Brain Ischemia - complications ; Brain Ischemia - drug therapy ; Female ; Fibrinolytic Agents - adverse effects ; Fibrinolytic Agents - therapeutic use ; Humans ; intravenous thrombolysis ; Ischemia ; Male ; Medical research ; Middle Aged ; mild stroke ; Stroke ; Stroke - complications ; Stroke - drug therapy ; stroke epidemiology ; stroke outcome ; Thrombolytic Therapy - adverse effects ; Time Factors ; Tissue Plasminogen Activator - adverse effects ; Tissue Plasminogen Activator - therapeutic use ; Treatment Outcome</subject><ispartof>Acta neurologica Scandinavica, 2014-04, Vol.129 (s198), p.37-40</ispartof><rights>2014 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2014 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2014 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</citedby><cites>FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24588505$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Logallo, N.</creatorcontrib><creatorcontrib>Kvistad, C. E.</creatorcontrib><creatorcontrib>Naess, H.</creatorcontrib><creatorcontrib>Waje-Andreassen, U.</creatorcontrib><creatorcontrib>Thomassen, L.</creatorcontrib><title>Mild stroke: safety and outcome in patients receiving thrombolysis</title><title>Acta neurologica Scandinavica</title><addtitle>Acta Neurol Scand</addtitle><description>Objectives The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients. Materials and methods All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria. Results Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS &gt;5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA. Conclusions This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Brain Ischemia - complications</subject><subject>Brain Ischemia - drug therapy</subject><subject>Female</subject><subject>Fibrinolytic Agents - adverse effects</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Humans</subject><subject>intravenous thrombolysis</subject><subject>Ischemia</subject><subject>Male</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>mild stroke</subject><subject>Stroke</subject><subject>Stroke - complications</subject><subject>Stroke - drug therapy</subject><subject>stroke epidemiology</subject><subject>stroke outcome</subject><subject>Thrombolytic Therapy - adverse effects</subject><subject>Time Factors</subject><subject>Tissue Plasminogen Activator - adverse effects</subject><subject>Tissue Plasminogen Activator - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0001-6314</issn><issn>1600-0404</issn><issn>1600-5449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1P3DAQhq2KqiwfB_4AisQFDgF_xklvdLVdKgE90ApulmNPqCGJt3YC7L-vYZc9IHUuo5GeeTTzInRA8ClJdaZ7OCWUMvEJTUiBcY455ltogjEmecEI30Y7MT6kiUrOv6BtykVZCiwm6NuVa20Wh-Af4WsWdQPDMtO9zfw4GN9B5vpsoQcH_RCzAAbck-vvs-FP8F3t22V0cQ99bnQbYX_dd9Hv77Nf04v88uf8x_T8Mje8KkReMyupkNYQbYi0BalxCY2tSy51BQwzUQsGxmqGBWe1rVhJy0I3EhvbGI7ZLjpeeRfB_x0hDqpz0UDbpvf9GBURmHPBJS8SevQBffBj6NN1rxSTtKgqmaiTFWWCjzFAoxbBdTosFcHqNViVzOot2MQero1j3YHdkO9JJuBsBTy7Fpb_N6nz69m7Ml9tuDjAy2ZDh0dVSCaFur2eK0pvyoqzqbpj_wA7CY_A</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Logallo, N.</creator><creator>Kvistad, C. E.</creator><creator>Naess, H.</creator><creator>Waje-Andreassen, U.</creator><creator>Thomassen, L.</creator><general>Blackwell Publishing Ltd</general><general>Hindawi Limited</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Mild stroke: safety and outcome in patients receiving thrombolysis</title><author>Logallo, N. ; Kvistad, C. E. ; Naess, H. ; Waje-Andreassen, U. ; Thomassen, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4965-b3d7257dc1ac17d61b08efdb847a9e3035b53ecda30543bd938286af70cdfc403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Brain Ischemia - complications</topic><topic>Brain Ischemia - drug therapy</topic><topic>Female</topic><topic>Fibrinolytic Agents - adverse effects</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Humans</topic><topic>intravenous thrombolysis</topic><topic>Ischemia</topic><topic>Male</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>mild stroke</topic><topic>Stroke</topic><topic>Stroke - complications</topic><topic>Stroke - drug therapy</topic><topic>stroke epidemiology</topic><topic>stroke outcome</topic><topic>Thrombolytic Therapy - adverse effects</topic><topic>Time Factors</topic><topic>Tissue Plasminogen Activator - adverse effects</topic><topic>Tissue Plasminogen Activator - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Logallo, N.</creatorcontrib><creatorcontrib>Kvistad, C. E.</creatorcontrib><creatorcontrib>Naess, H.</creatorcontrib><creatorcontrib>Waje-Andreassen, U.</creatorcontrib><creatorcontrib>Thomassen, L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Acta neurologica Scandinavica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Logallo, N.</au><au>Kvistad, C. E.</au><au>Naess, H.</au><au>Waje-Andreassen, U.</au><au>Thomassen, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mild stroke: safety and outcome in patients receiving thrombolysis</atitle><jtitle>Acta neurologica Scandinavica</jtitle><addtitle>Acta Neurol Scand</addtitle><date>2014-04</date><risdate>2014</risdate><volume>129</volume><issue>s198</issue><spage>37</spage><epage>40</epage><pages>37-40</pages><issn>0001-6314</issn><eissn>1600-0404</eissn><eissn>1600-5449</eissn><coden>ANRSAS</coden><abstract>Objectives The aim of this study was to compare the short‐term clinical outcome of patients with acute cerebral ischemia and mild symptoms receiving rt‐PA with that of patients with acute cerebral ischemia and mild symptoms not treated with rt‐PA, and to investigate the frequency of symptomatic intracranial hemorrhage (sICH) in these patients. Materials and methods All patients with confirmed ischemic stroke/TIA and mild symptoms were included. Mild symptoms were defined as NIHSS score ≤5 on admission. Functional outcome was assessed with modified Rankin Scale (mRS) at day 7 or at earlier discharge. Excellent outcome was defined as mRS = 0. sICH was defined according to both NINDS and ECASS III criteria. Results Of 2753 patients with confirmed ischemic stroke/TIA admitted between February 2006 and February 2013, 966 (35.3%) were excluded because of having admission NIHSS &gt;5. A total of 1791 patients presented with mild symptoms on admission (NIHSS ≤5), of which 158 (8.8%) patients received rt‐PA. Treatment with rt‐PA and early admission were independently associated with excellent outcome. Higher NIHSS score on admission and prior ischemic stroke were independently associated with poor outcome. Three (1.9%) sICH were diagnosed in rt‐PA‐treated patients and one (0.1%) in patients not receiving rt‐PA. Conclusions This study highlights the efficacy of rt‐PA in patients with acute cerebral ischemia presenting with mild symptoms and confirms the low‐risk profile of this treatment.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>24588505</pmid><doi>10.1111/ane.12235</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-6314
ispartof Acta neurologica Scandinavica, 2014-04, Vol.129 (s198), p.37-40
issn 0001-6314
1600-0404
1600-5449
language eng
recordid cdi_proquest_miscellaneous_1504454746
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Brain Ischemia - complications
Brain Ischemia - drug therapy
Female
Fibrinolytic Agents - adverse effects
Fibrinolytic Agents - therapeutic use
Humans
intravenous thrombolysis
Ischemia
Male
Medical research
Middle Aged
mild stroke
Stroke
Stroke - complications
Stroke - drug therapy
stroke epidemiology
stroke outcome
Thrombolytic Therapy - adverse effects
Time Factors
Tissue Plasminogen Activator - adverse effects
Tissue Plasminogen Activator - therapeutic use
Treatment Outcome
title Mild stroke: safety and outcome in patients receiving thrombolysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mild%20stroke:%20safety%20and%20outcome%20in%20patients%20receiving%20thrombolysis&rft.jtitle=Acta%20neurologica%20Scandinavica&rft.au=Logallo,%20N.&rft.date=2014-04&rft.volume=129&rft.issue=s198&rft.spage=37&rft.epage=40&rft.pages=37-40&rft.issn=0001-6314&rft.eissn=1600-0404&rft.coden=ANRSAS&rft_id=info:doi/10.1111/ane.12235&rft_dat=%3Cproquest_cross%3E3235139881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1503726997&rft_id=info:pmid/24588505&rfr_iscdi=true